HomeStocksSANDUPHQ

S

Sandu Pharmaceuticals

SANDUPHQ Share Price

Healthcare

48.60

-1.40 (-2.80%)loss

as on 03 Apr 2025 at 15:28

1D

BSE

Bulb

Today Sandu Pharmaceuticals opened at 49.75 while its previous close was at 50.00. In todays trading session SANDUPHQ reached a high of 50.00 and low of 48.58. The average traded price for today is 49.33. The 50 DMA stands at 14.49 and 200 DMA is at 18.90. Looking at intraday trend, the stock is in Downtrend.

TradingView Logo

Get 10+ Layouts, 100+ Indicators, Custom Timeframes & All Drawing Tools for FREE.

SANDUPHQ Stock Performance

Markets Today

High

50.00

Low

48.58

Open at

49.75

Prev Close

50.00

Volumes

3,545

Avg Price

49.33

Lower Circuit

38.94

Upper Circuit

58.40

Last Traded Details

Quantity

530

Time

15:28:47

Price Movement

48.58
48.60
50.00
Loss 0.04%down side
up side2.80% profit

Historical Performance

3 M High

62.80

3 M Low

45.15

1 Yr High

69.50

1 Yr Low

45.15

3 Yr High

86.00

3 Yr Low

45.15

5 Yr High

86.00

5 Yr Low

11.70

1-Year Performance

45.15
48.60
69.50
loss0.04%down side
up side2.80% profit

SANDUPHQ Latest News

news

No news for this stock at the moment.


SANDUPHQ Share Price History

Close Price

Volume

SANDUPHQ share price in last 10 trading sessions

DayOpenCloseChange%Day HighDay LowVolume
02 Apr 2025164.55164.00
-2.38% Loss
164.55164.008
28 Mar 2025168.60167.90
-0.63% Loss
168.60167.9014
27 Mar 2025169.00168.95
4.32% profit
169.00168.953
26 Mar 2025162.00161.65
4.39% profit
162.00161.656
25 Mar 2025154.70154.55
4.24% profit
154.70154.5564
24 Mar 2025147.95148.00
-0.95% Loss
148.00145.00109
21 Mar 2025149.40149.40
4.69% profit
149.40149.401
20 Mar 2025142.95142.40
-0.25% Loss
143.00136.95846
19 Mar 2025130.25142.75
4.45% profit
143.00130.251,030
18 Mar 2025136.40136.40
0.00% profit
136.40133.0038

SANDUPHQ Fundamentals

View Fundamentals arrow

Company Valuation

Market Cap (₹ Cr.)

48

PE Ratio

33.10

PB Ratio

1.18

Dividend Yield

1.60%

ROE

3.60%

ROCE

5.11%

Book Value (₹)

42.29

Face Value (₹)

10.00


Share Holding Pattern

Held ByDec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters
42.90%42.90%42.90%42.90%42.90%
Domestic Institutional Investors (DII)
0.01%0.01%0.01%0.01%0.01%
Foreign Institutional Investors (FII)
0.00%0.00%0.00%0.00%0.00%
Public Investors
45.19%44.16%44.25%34.97%35.34%
Government
0.00%0.00%0.00%0.00%0.00%

Promoters

Domestic Institutional Investors (DII)

Foreign Institutional Investors (FII)

Public Investors

Government


SANDUPHQ Investment Returns

1 Week

1 Month

3 Months

6 Months

9 Months

SIP Logo

Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.


SANDUPHQ Technicals

View Technicals arrow

Moving Averages

PeriodSimpleSignal
5-SMA10.32Bearish
10-SMA11.14Bearish
20-SMA12.11Bearish
50-SMA14.49Bearish
100-SMA16.07Bearish
200-SMA18.90Bearish

Technical Indicators

IndicatorValueAction
RSI(14)27.10Neutral
ATR(14)0.76Less Volatile
STOCH(9,6)9.50Oversold
STOCH RSI(14)-0.00Oversold
MACD(12,26)-0.19Bearish
ADX(14)32.90Strong Trend

Summary of Technical Indicators for SANDUPHQ


SANDUPHQ Financials Summary
View By:
Revenue

In Crores

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
1718161718
EBITDA

In Crores

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
11101

Net Profit

In Crores

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
10101
EPS
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
0.570.210.620.171.95

SANDUPHQ Financials

View By:

Income Statement

In Crores

Quarterly StatementSep 2023Dec 2023Mar 2024Jun 2024Sep 2024
Revenue1718161718
Expenses1617151717
Operating Profit11101
Operating Profit Margin %5%3%4%2%5%
Other Income00000
Interest00000
Depreciation00000
Profit Before Tax10101
Tax %28%45%18%37%32%
Net Profit10101
EPS10102

Balance Sheet

In Crores

Yearly Balance SheetMar 2023Mar 2024
Share Capital1010
Reserve & Surplus3031
Minority Interest00
Non Current Liabilities11
Current Liabilities1411
Total Liabilities5452
Fixed Assets1718
Capital Work in Progress00
Investments1010
Other Assets2824
Total Assets5452

Cash Flow

In Crores

Yearly Cash FlowMar 2023Mar 2024
Operating Activities01
Investing Activities1-1
Financing Activities1-1
Net Cash Flow1-1
ScanX Logo

Get In-depth View of SANDUPHQ Quaterly Results, Balance Sheet, Cashflows & Corporate Action.

Use Screener

Corporate Actions

No Data

Sorry, No Corporate Actions at this Moment!


SANDUPHQ Revenue Growth

All values are in Crores

Revenue

Profit

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2023-2468
2.96% profit
2
-4.15% Loss
FY 2022-2366
-0.23% Loss
2
-4.12% Loss
FY 2021-2266
11.48% profit
2
45.47% profit






What’s New In The Market
icon
C

Cholamandalam Investment and Finance: Strong Growth, But Overvalued Says Nuvama

sentiment_img

Nuvama initiates 'Hold' rating on Cholamandalam Investment and Finance with a target price of Rs 1,600, citing strong profitability and AUM growth but expensive valuation at 4.1x BV FY26E. The company is expected to maintain 30% earnings growth over FY25-27E, with improving ROA and declining credit costs. However, delinquencies have increased, with GS3 rising to 2.9% from 2.5% in Mar-24.

CHOLAFIN

1,445.45

-14.80
(-1.01%) profit
25 minutes ago

icon
T

Tejas Networks: BSNL's 5G Expansion Boosts Growth Prospects

sentiment_img

Tejas Networks is benefiting from BSNL's 5G standalone rollout, having supplied equipment for 86,000 sites. BSNL received ₹61,000 crore worth of 5G spectrum and plans nationwide expansion. Tejas' shares surged 9.13% to ₹877.15 on BSE.

TEJASNET

876.35

73.35
(9.13%) profit
1 hours ago

icon
S

Schaeffler India: Intensifies Anti-Counterfeit Efforts with Successful Raids

sentiment_img

Schaeffler India conducted about 100 legal activities including raids in Delhi, Mumbai, and Kolkata to combat counterfeit products. The company seized fake items branded as FAG, INA, and LuK. Measures implemented include unique identification codes and a mobile app for product authentication.

SCHAEFFLER

3,287.25

-14.50
(-0.44%) profit
2 hours ago

FAQs

Sandu Pharmaceuticals share price as of today is ₹ 48.60 as on 03 Apr 2025 at 15:28.
The 52W high of Sandu Pharmaceuticals is ₹ 69.50 and 52W low is ₹ 45.15 as of 03 Apr 2025 at 15:28.
The past returns of Sandu Pharmaceuticals share are -
  • Past 1 year: -24.30%
  • Past 3 years: -33.06%
  • Past 5 years: 300.66%
The PE and PB ratio of Sandu Pharmaceuticals stands at 33.10 and 1.18 respectively as on 03 Apr 2025 at 15:28.
The EPS of Sandu Pharmaceuticals is 1.95 for the quarter ended Sep 2024 and 1.51 for the financial year 2023-24.
The shareholding pattern of Sandu Pharmaceuticals is as follows:
  • DIIs - 0.01%
  • FII - 0.00%
  • Promoters - 42.90%
  • Public Investors 35.34%
  • Goverenment - 0.00%
Yes, you can buy shares of Sandu Pharmaceuticals online by opening Demat account with Dhan.
If you are a Dhan user already, you can buy Sandu Pharmaceuticals stocks from Dhan Trading App or Web Trading Platform. If you are new to Dhan follow the below steps:
  1. Download the Dhan App to Open a Demat Account
  2. Navigate to the “Money Tab”
  3. Add money to your account
  4. Search for Sandu Pharmaceuticals share
  5. Tap on “Buy”
With Dhan you can start a daily, weekly or monthly SIP in Sandu Pharmaceuticals.
You can easily buy the shares of Sandu Pharmaceuticals even after the markets are closed using the After Market Order feature on Dhan Trading App.
Candle bars with Screen
Invest in SANDUPHQ
Candle bars with Screen

Pay Zero Brokerage on Delivery

Candle bars with Screen

Open FREE Demat Account

Indian Flag

+91

Or Scan the QR Code to download the Dhan App

QR code Logo


Invest & Trade with a Trading
Platform That's icon

Open your Dhan Account in minutes!


border

Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2025 Moneylicious Securities Private Limited. All rights reserved. CIN: U74999MH2012PTC433549 Moneylicious Securities is part of Raise Financial Services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India.
Corporate Office: 302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai - 400066, Maharashtra, India. Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Moneylicious Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client in the chat section are for support purposes only, and any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Moneylicious Securities Private Limited. All DHAN clients are registered under Moneylicious Securities Private Limited. Clients are advised to refer to our company as Moneylicious Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / Moneylicious / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Moneylicious Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Saarthi 2.0 Mobile App for Investors